Загрузка...
Monoclonal antibody therapy in multiple sclerosis: Paradigm shifts and emerging challenges
Therapeutic approaches to multiple sclerosis (MS) are based on altering the functions of the immune system, either by using broad immunosuppressive drugs used for transplantation rejection and rheumatology, or by modulating them more discreetly with beta interferon and synthetic amino-acid copolymer...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Landes Bioscience
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3011221/ https://ncbi.nlm.nih.gov/pubmed/21124072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.2.6.13270 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|